The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Acquired Expression of Periostin by Human Breast Cancers Promotes Tumor Angiogenesis through Up-Regulation of Vascular Endothelial Growth Factor Receptor 2 Expression
Open accessAbstract
The late stages of human breast cancer development are poorly understood complex processes associated with the expression of genes by cancers that promote specific tumorigenic activities, such as angiogenesis. Here, we describe the identification of periostin as a mesenchyme-specific gene whose acquired expression by human breast cancers leads to a significant enhancement in tumor progression and angiogenesis. Undetectable in normal human breast tissues, periostin was found to be overexpressed by the vast majority of human primary breast cancers examined. Tumor cell lines engineered to overexpress periostin showed a phenotype of accelerated growth and angiogenesis as xenografts in immunocompromised animals. The underlying mechanism of periostin-mediated induction of angiogenesis was found to derive in part from the up-regulation of the vascular endothelial growth factor receptor Flk-1/KDR by endothelial cells through an integrin alpha(v)beta(3)-focal adhesion kinase-mediated signaling pathway. These findings demonstrate the presence of a novel mechanism by which tumor angiogenesis is acquired with the expression of a mesenchyme-specific gene as a crucial step in late stages of tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536 · cited 1×
“In breast cancer, for example, such investigations have led to the application of gene array analysis in the diagnosis, prognosis, and design of rational treatment of patients according to the molecular signatures of the individual tumors (21, 22, 32, 35).”
BackgroundSerial Analysis of Gene Expression
Velculescu, V. E., Zhang, L., Vogelstein, B., & Kinzler, K. W. (1995) · Science · doi:10.1126/science.270.5235.484 · Cited by 3,711
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699 · cited 1×
“VEGF and its receptor Flk-1/KDR have been extensively documented to be involved in the induction of angiogenesis during the development of solid tumors (13, 19, 28, 36).”
BackgroundKim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
Induction of angiogenesis during the transition from hyperplasia to neoplasia
Folkman, J., Watson, K., Ingber, D., & Hanahan, D. (1989) · Nature · doi:10.1038/339058a0 · Cited by 1,879 · cited 2×
“After reaching a critical mass, cancer cells have to find ways to promote angiogenesis in order to progress and expand during late stages of tumorigenesis (4, 5).”
BackgroundLyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860 · cited 1×
“Importantly, the acquired expression of periostin by tumors of epithelial origin described here is certainly not an isolated and rare event during tumorigenesis, since a number of other examples of acquired expression of mesenchymal genes by epithelial-cell-derived tumors can be found in the literature (17, 18, 23).”
BackgroundDistinctive gene expression patterns in human mammary epithelial cells and breast cancers
Perou, C. M., Jeffrey, S. S., van de Rijn, M., Rees, C. A., Eisen, M. B., Ross, D. T., Pergamenschikov, A., Williams, C. F., Zhu, S. X., Lee, J. C. F., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9212 · Cited by 1,402
Predicting the clinical status of human breast cancer by using gene expression profiles
West, M., Blanchette, C., Dressman, H., Huang, E., Ishida, S., Spang, R., Zuzan, H., Olson, J. A., Marks, J. R., & Nevins, J. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201162998 · Cited by 1,318
Self-citationVEGF-D promotes the metastatic spread of tumor cells via the lymphatics
Stacker, S. A., Caesar, C., Baldwin, M. E., Thornton, G. E., Williams, R. A., Prevo, R., Jackson, D. G., Nishikawa, S.-I., Kubo, H., & Achen, M. G. (2001) · Nature Medicine · doi:10.1038/84635 · Cited by 1,246
Gene Expression Profiles in Normal and Cancer Cells
Zhang, L., Zhou, W., Velculescu, V. E., Kern, S. E., Hruban, R. H., Hamilton, S. R., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.276.5316.1268 · Cited by 1,184
Inhibition of VEGF receptors causes lung cell apoptosis and emphysema
Kasahara, Y., Tuder, R. M., Taraseviciene-Stewart, L., Le Cras, T. D., Abman, S., Hirth, P. K., Waltenberger, J., & Voelkel, N. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10259 · Cited by 1,112
Horiuchi, K., Amizuka, N., Takeshita, S., Takamatsu, H., Katsuura, M., Ozawa, H., Toyama, Y., Bonewald, L. F., & Kudo, A. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.7.1239 · Cited by 975
Absence of cancer–associated changes in human fibroblasts immortalized with telomerase
Morales, C. P., Holt, S. E., Ouellette, M., Kaur, K. J., Yan, Y., Wilson, K. S., White, M. A., Wright, W. E., & Shay, J. W. (1999) · Nature Genetics · doi:10.1038/5063 · Cited by 803
Jiang, X.-R., Jimenez, G., Chang, E., Frolkis, M., Kusler, B., Sage, M., Beeche, M., Bodnar, A. G., Wahl, G. M., Tlsty, T. D., et al. (1999) · Nature Genetics · doi:10.1038/5056 · Cited by 668
Takeshita, S., Kikuno, R., Tezuka, K., & Amann, E. (1993) · Biochemical Journal · doi:10.1042/bj2940271 · Cited by 664
Gillan, L., Matei, D. E., Fishman, D. A., Gerbin, C. S., Karlan, B. Y., & Chang, D. D. (2002) · PubMed · Cited by 629
A public database for gene expression in human cancers.
Lal, A., Lash, A., Altschul, S. F., Velculescu, V. E., Zhang, L., McLendon, R. E., Marra, M. A., Prange, C. K., Morin, P. J., Polyák, K., et al. (1999) · PubMed · Cited by 461
Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo.
Millauer, B., Longhi, M. P., Plate, K. H., Shawver, L. K., Risau, W., Ullrich, A., & Strawn, L. M. (1996) · PubMed · Cited by 413
Tumor angiogenesis and tissue factor
Folkman, J. (1996) · Nature Medicine · doi:10.1038/nm0296-167 · Cited by 293
Ledda, M. F., Adris, S., Bravo, A. I., Kairiyama, C., Bover, L., Chernajovsky, Y., Mordoh, J., & Podhajcer, O. L. (1997) · Nature Medicine · doi:10.1038/nm0297-171 · Cited by 229
Analysing uncharted transcriptomes with SAGE
Velculescu, V. E., Vogelstein, B., & Kinzler, K. W. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(00)02114-4 · Cited by 213
Lin, P. C., Sankar, S., Shan, S. Q., Dewhirst, M. W., Polverini, P. J., Quinn, T. Q., & Peters, K. G. (1998) · PubMed · Cited by 199
ABU-GHAZALEH, R., Kabir, J., Jia, H., Mel, L. O. B. O., & Zachary, I. C. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3600255 · Cited by 197
Dougher, M., & Terman, B. I. (1999) · Oncogene · doi:10.1038/sj.onc.1202478 · Cited by 193
Rich, J. N., Shi, Q., Hjelmeland, M. D., Cummings, T. J., Kuan, C., Bigner, D. D., Counter, C. M., & Wang, X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211498200 · Cited by 148
Self-citationElevated Serum Periostin Levels in Patients with Bone Metastases from Breast but not Lung Cancer
Sasaki, H., Yu, C., Dai, M., Tam‐Amersdorfer, C., Loda, M. F., Auclair, D., Chen, L. B., & ELIAS, A. D. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1021899904332 · Cited by 143
Biroccio, A., Candiloro, A., Mottolese, M., Sapora, O., Albini, A., Zupi, G., & Bufalo, D. D. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.5.652 · Cited by 139
Regulation of angiogenesis by SPARC and angiostatin: implications for tumor cell biology
Jendraschak, E., & Sage, E. H. (1996) · Seminars in Cancer Biology · doi:10.1006/scbi.1996.0019 · Cited by 113
Sasaki, H., Auclair, D., Fukai, I., Kiriyama, M., Yamakawa, Y., Fujii, Y., & Chen, L. B. (2001) · Cancer · Cited by 109
Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC
Vajkoczy, P., Menger, M. D., Goldbrunner, R., Ge, S., Fong, T. A. T., Vollmar, B., Schilling, L., Ullrich, A., Hirth, K. P., Tonn, J. C., et al. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000715)87:2<261::aid-ijc18>3.0.co;2-6 · Cited by 74
Serum level of the periostin, a homologue of an insect cell adhesion molecule, in thymoma patients
Sasaki, H., Auclair, D., Kaji, M., Fukai, I., Kiriyama, M., Yamakawa, Y., Fujii, Y., & Chen, L. B. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00633-4 · Cited by 55
Tang, S., Gao, Y., & Ware, J. A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.5.1073 · Cited by 38
Lochter, A., Werb, Z., & Bissell, M. J. (1999) · Matrix Biology · doi:10.1016/s0945-053x(99)00036-0 · Cited by 18
Cited by
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296
Microenvironmental regulation of tumour angiogenesis
De Palma, M., Biziato, D., & Petrova, T. V. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.51 · Cited by 1,847
Woodruff, P. G., Boushey, H. A., Dolganov, G. M., Barker, C. S., Yang, Y. H., Donnelly, S., Ellwanger, A., Sidhu, S. S., Dao-Pick, T. P., Pantoja, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707413104 · Cited by 828
Heerboth, S., Housman, G., Leary, M., Longacre, M., Byler, S., Lapinska, K., Willbanks, A., & Sarkar, S. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0048-3 · Cited by 739
The extracellular matrix in breast cancer
Insua-Rodríguez, J., & Oskarsson, T. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.017 · Cited by 470
Metadata
- Authors
- Shao, R., Bao, S., Bai, X., Blanchette, C., Anderson, R. M., Dang, T., Gishizky, M. L., Marks, J. R., & Wang, X.-F.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2004-05-01
- Volume
- 24
- Issue
- 9
- Pages
- 3992-4003
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2154613259
- Cited by
- 319
- References
- 35
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.